With regard to the oral micro-environment of participants in our study, levels of pro-inflammatory cytokines (e.g., IL-1β, IL-6, and TNF-α) were significantly higher in the AD group than in the preclinical stage of AD groups, in accordance with previous studies (Bathini et al., 2020). The gene discussed is IL1B; the disease is Alzheimer disease.